Tonix Pharmaceuticals Holding (TNXP) Prepaid Assets (2010 - 2026)

Tonix Pharmaceuticals Holding's (TNXP) quarterly Prepaid Assets came in at $9.2 million in Q1 2026, up 762.9% year-on-year from $1.1 million in Q1 2025, and up 459.58% quarter-over-quarter from $1.6 million in Q4 2025.

Tonix Pharmaceuticals Holding (TNXP) Prepaid Assets (2010 - 2026) Analysis & Trends

Tonix Pharmaceuticals Holding's Prepaid Assets history runs 17 years deep, the most recent figure standing at $9.2 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 762.9% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $9.2 million, a 762.9% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 18.53% from the prior year.
  • Prepaid Assets grew to $9.2 million in Q1 2026 per TNXP's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $14.8 million in Q2 2022 and bottomed at $686000.0 in Q2 2025.
  • The 5-year median for Prepaid Assets is $9.2 million (2023), against an average of $7.4 million.
  • Across the five-year window, Prepaid Assets plunged 91.77% in 2025 and soared 762.9% in 2026, its largest moves.
  • Year by year, Prepaid Assets stood at $1.3 million in 2022, then soared by 620.08% to $9.2 million in 2023, then plunged by 84.84% to $1.4 million in 2024, then advanced by 18.53% to $1.6 million in 2025, then surged by 459.58% to $9.2 million in 2026.
  • Per Business Quant, the three latest TNXP Prepaid Assets figures stand at $9.2 million (Q1 2026), $1.6 million (Q4 2025), and $8.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 473.74 Bn 468.95 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.07 Bn 114.82 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.00 Bn 61.24 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.96 Bn 50.77 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Tonix Pharmaceuticals Holding 142.14 Mn 142.14 Mn 5.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.23 Mn
Dec 31, 2025 1.65 Mn
Sep 30, 2025 8.81 Mn
Jun 30, 2025 686,000.00
Mar 31, 2025 1.07 Mn
Dec 31, 2024 1.39 Mn
Sep 30, 2024 2.13 Mn
Jun 30, 2024 8.34 Mn
Mar 31, 2024 10.70 Mn
Dec 31, 2023 9.18 Mn
Sep 30, 2023 9.54 Mn
Jun 30, 2023 12.01 Mn
Mar 31, 2023 11.75 Mn
Dec 31, 2022 1.28 Mn
Sep 30, 2022 11.16 Mn
Jun 30, 2022 14.77 Mn
Mar 31, 2022 12.55 Mn
Dec 31, 2021 1.48 Mn
Sep 30, 2021 12.11 Mn
Jun 30, 2021 11.55 Mn